Gambro AB - Strategic SWOT Analysis Review

Document Sample
Gambro AB - Strategic SWOT Analysis Review Powered By Docstoc
					                                   Gambro AB - Strategic SWOT Analysis Review
        Reference Code: GDME618SA                                                                                            Publication Date: MAR 2013

          P.O. Box 10101, Magistratsvagen 16                 Phone             +46 46 169000                    Revenue         10,836 (million SEK)
          Lund, province of Scania                           Fax               +46 46 169696                    Net Profit      NA
          22010                                              Website           www.gambro.com                   Employees       7,205 (Estimated)
          Sweden                                             Exchange                                           Industry        Medical Equipment

       Company Overview
       Gambro AB (Gambro) is a global medical technology company. It carries out the development, manufacture and marketing of
       products, therapies and services for in-center dialysis, home dialysis, and blood purification in intensive care markets. It offers
       hemodialysis products, acute care products, vascular access products, myeloma kidney therapy systems and water systems. The
       company has research and development facilities in Sweden, France, Germany and Italy. It operates in North America, Europe,
       Africa and Asia. Gambro is a subsidiary of Indap AB, which is jointly owned by Investor AB and EQT. The company is
       headquartered in Lund, Sweden.
       Key Executives                                                             SWOT Analysis
                     Name                                Title                     Gambro AB, SWOT Analysis
         Guido Oelkers                     Chief Executive Officer                 Strengths                            Weaknesses
         Jerry McIntyre                    Chief Legal Counsel
                                                                                   Geographical Diversity               Product Recalls
         Juan Bosch                        Chief Medical Officer
                                                                                   Competitive Product Offerings        Declining Revenues
         Hans Henriksson                   Senior Vice President,
                                           Human Resources and
                                           Communications                          Opportunities                        Threats
         Javad Seyedzadeh                  Senior Vice President,
                                           Quality Assurance and                   Expansion in High Growth             Stringent Government
                                           Regulatory Affairs                      Markets                              Regulations
        Source: Company Website, Primary and Secondary Research,                   Growing Aged Population              Cost Containment Pressures
        GlobalData


        Key Competitors                                                           Source: Company Website, Primary and Secondary Research, GlobalData

         NxStage Medical, Inc.
         DaVita Inc.
         Nipro Corporation
         Fresenius SE & Co. KGaA
        Asahi Kasei Corporation
        Source: Company Website, Primary and Secondary Research,
        GlobalData




Gambro AB - Strategic SWOT Analysis Review                                                                                        Reference Code: GDME618SA
Source : www.globalcompanyintelligence.com                                                                                                              Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Gambro AB - Key Facts...................................................................................................................................................................... 5
       Gambro AB - Key Employees............................................................................................................................................................. 6
       Gambro AB - Key Employee Biographies........................................................................................................................................... 7
       Gambro AB - Major Products and Services ........................................................................................................................................ 8
       Gambro AB - Medical Equipment Pipeline Products Data ................................................................................................................ 10
          Gambro AB Pipeline Products by Equipment Type ...................................................................................................................... 10
          Gambro AB Pipeline Products by Development Stage ................................................................................................................. 11
       Gambro AB - History ........................................................................................................................................................................ 12
       Gambro AB - Company Statement ................................................................................................................................................... 16
       Gambro AB - Locations And Subsidiaries ........................................................................................................................................ 17
          Head Office ................................................................................................................................................................................... 17
          Other Locations & Subsidiaries ..................................................................................................................................................... 17
       Gambro AB - Key Manufacturing Facilities ....................................................................................................................................... 20
       Section 2 – Company Analysis ......................................................................................................................................................... 21
       Gambro AB - Business Description .................................................................................................................................................. 21
          Business Description - Renal Care ............................................................................................................................................... 21
             Renal Care - Overview .............................................................................................................................................................. 21
             Renal Care - Market View ......................................................................................................................................................... 21
             Renal Care - Technology .......................................................................................................................................................... 22
       Gambro AB - Corporate Strategy ..................................................................................................................................................... 23
       Gambro AB - SWOT Analysis .......................................................................................................................................................... 24
          SWOT Analysis - Overview........................................................................................................................................................... 24
          Gambro AB - Strengths................................................................................................................................................................. 24
             Strength - Geographical Diversity ............................................................................................................................................. 24
             Strength - Competitive Product Offerings .................................................................................................................................. 24
             Strength - Focused Research and Development ...................................................................................................................... 24
          Gambro AB - Weaknesses ........................................................................................................................................................... 25
             Weakness - Product Recalls ..................................................................................................................................................... 25
             Weakness - Declining Revenues .............................................................................................................................................. 25
          Gambro AB - Opportunities........................................................................................................................................................... 25
             Opportunity - Expansion in High Growth Markets ..................................................................................................................... 25
             Opportunity - Growing Aged Population .................................................................................................................................... 25
             Opportunity - Perpetual Innovation............................................................................................................................................ 26
             Opportunity - Acquisition by Baxter International Inc. ................................................................................................................ 26
          Gambro AB - Threats .................................................................................................................................................................... 26
             Threat - Stringent Government Regulations .............................................................................................................................. 26
             Threat - Cost Containment Pressures ....................................................................................................................................... 26
             Threat - Competitive Market ...................................................................................................................................................... 26
             Threat - Rapid Technological Changes ..................................................................................................................................... 27
       Gambro AB - Key Competitors ......................................................................................................................................................... 28
       Section 3 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 29



Gambro AB - Strategic SWOT Analysis Review                                                                                                                          Reference Code: GDME618SA
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
          Gambro AB, Medical Equipment, Deals By Year, 2007 to YTD 2013 ........................................................................................... 29
          Gambro AB, Medical Equipment, Deals By Type, 2007 to YTD 2013 .......................................................................................... 30
       Gambro AB, Recent Deals Summary ............................................................................................................................................... 31
       Section 4 – Company’s Recent Developments ................................................................................................................................ 32
          Gambro AB, Recent Developments .............................................................................................................................................. 32
             Jan 24, 2013: Gambro's Molecular Adsorbent Recirculating System Receives FDA 510(k) Clearance For Treatment Of
             Hepatic Encephalopathy ........................................................................................................................................................... 32
             Apr 16, 2012: Gambro Introduces SelectBag Citrate To Improve Quality Of Life For Hemo
				
DOCUMENT INFO
Description: Gambro AB (Gambro) is a global medical technology company. It carries out the development, manufacture and marketing of products, therapies and services for in-center dialysis, home dialysis, and blood purification in intensive care markets. It offers hemodialysis products, acute care products, vascular access products, myeloma kidney therapy systems and water systems. The company has research and development facilities in Sweden, France, Germany and Italy. It operates in North America, Europe, Africa and Asia. Gambro is a subsidiary of Indap AB, which is jointly owned by Investor AB and EQT. The company is headquartered in Lund, Sweden.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.